Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84


Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.

Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D.

Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.


2017 Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry.

Lassalle M, Monnet E, Ayav C, Hogan J, Moranne O, Couchoud C; REIN registry.

Transpl Int. 2019 May 30. doi: 10.1111/tri.13466. [Epub ahead of print]


[Towards an extension of the REIN registry to patients with chronic kidney disease at stage 5 not treated with dialysis or transplantation? A pilot study].

Vigneau C, Ayav C, Noël N, Gomis S, Glaudet F, Siébert M, Kessler M, Nogier MB, Villar E, Allot V, Edet S, Glowacki F, Baudoin V, Allain-Launay E, Dunand O, Moranne O, Hogan J, Couchoud C; registre REIN.

Nephrol Ther. 2019 Jun;15(3):143-151. doi: 10.1016/j.nephro.2018.11.010. Epub 2019 May 1. French.


Not only disease activity but also chronic hypertension and overweight are determinants of pregnancy outcomes in patients with systemic lupus erythematosus.

Normand G, Sens F, Puthet J, Jourde-Chiche N, Lemoine S, Chauveau D, Moranne O, Rémy P, Doret M, Daugas E, Juillard L; French Collaborative Group on Lupus Nephritis.

Lupus. 2019 Apr;28(4):529-537. doi: 10.1177/0961203319832097. Epub 2019 Feb 24.


Increased incidence of acute kidney injury requiring dialysis in metropolitan France.

Garnier F, Couchoud C, Landais P, Moranne O.

PLoS One. 2019 Feb 7;14(2):e0211541. doi: 10.1371/journal.pone.0211541. eCollection 2019.


Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy.

Legeai C, Andrianasolo RM, Moranne O, Snanoudj R, Hourmant M, Bauwens M, Soares J, Jacquelinet C, Couchoud C, Macher MA.

Am J Transplant. 2018 Nov;18(11):2695-2707. doi: 10.1111/ajt.15110. Epub 2018 Oct 18.


Predicting early death in older adults with cancer.

Boulahssass R, Gonfrier S, Ferrero JM, Sanchez M, Mari V, Moranne O, Rambaud C, Auben F, Hannoun Levi JM, Bereder JM, Bereder I, Baque P, Turpin JM, Frin AC, Ouvrier D, Borchiellini D, Largillier R, Sacco G, Delotte J, Arlaud C, Benchimol D, Durand M, Evesque L, Mahamat A, Poissonnet G, Mouroux J, Barriere J, Benizri E, Piche T, Guigay J, Francois E, Guerin O.

Eur J Cancer. 2018 Sep;100:65-74. doi: 10.1016/j.ejca.2018.04.013. Epub 2018 Jun 29.


One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate.

Bataille Y, Costerousse O, Bertrand OF, Moranne O, Pottel H, Delanaye P.

PLoS One. 2018 Jul 6;13(7):e0199773. doi: 10.1371/journal.pone.0199773. eCollection 2018.


Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. Erratum in: Kidney Int Rep. 2018 Aug 30;3(6):1506.


Outcomes of acute kidney injury depend on initial clinical features: a national French cohort study.

Riffaut N, Moranne O, Hertig A, Hannedouche T, Couchoud C.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2218-2227. doi: 10.1093/ndt/gfy137.


Treatment plans and outcomes in elderly patients reaching advanced chronic kidney disease.

Moranne O, Fafin C, Roche S, Francois M, Allot V, Potier J, Babici D, Lobbedez T, Matignon M, Mariat C, Vigneau C, Couchoud C.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2182-2191. doi: 10.1093/ndt/gfy046.


[Micro-inflammation and digestive bacterial translocation in chronic kidney disease].

Olivier V, Dunyach-Remy C, Lavigne JP, Moranne O.

Nephrol Ther. 2018 May;14(3):135-141. doi: 10.1016/j.nephro.2017.10.005. Epub 2017 Dec 30. Review. French.


[Survey on the perception of competencies acquired during nephrology resident training in France].

Moranne O, Peraldi MN, Choukroun G, Brunet P, Rondeau É, Moulin B.

Nephrol Ther. 2017 Dec;13(7):518-524. doi: 10.1016/j.nephro.2017.01.026. Epub 2017 Oct 12. French.


CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients.

Gagneux-Brunon A, Botelho-Nevers E, Delanaye P, Lucht F, Frésard A, Cazorla C, Guglielminotti C, Fafin C, Mariat C, Moranne O.

Med Mal Infect. 2017 Jun;47(4):266-270. doi: 10.1016/j.medmal.2017.04.001. Epub 2017 May 9.


Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals.

Ryom L, Mocroft A, Kirk O, Reiss P, Ross M, Smith C, Moranne O, Morlat P, Fux CA, Sabin C, Phillips A, Law M, Lundgren JD; D:A:D study group.

AIDS. 2017 Jun 1;31(9):1261-1270. doi: 10.1097/QAD.0000000000001464.


[Factors affecting the choice of peritoneal dialysis: Perspective of patients and nephrologists].

Habib A, Durand AC, Brunet P, Duval-Sabatier A, Moranne O, Bataille S, Benhaim L, Bargas É, Gentile S.

Nephrol Ther. 2017 Apr;13(2):93-102. doi: 10.1016/j.nephro.2016.07.451. Epub 2017 Feb 1. French.


Restricted mean survival time over 15 years for patients starting renal replacement therapy.

Couchoud C, Dantony E, Elsensohn MH, Villar E, Vigneau C, Moranne O, Rabilloud M, Ecochard R.

Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii60-ii67. doi: 10.1093/ndt/gfw386.


18F-Florbetaben: A New Tool for Amyloidosis Staging?

D'Estanque E, Chambert B, Moranne O, Kotzki PO, Boudousq V.

Clin Nucl Med. 2017 Jan;42(1):50-53.


Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.

Islam MS, Hassan ZA, Chalmin F, Vido S, Berrada M, Verhelst D, Donnadieu P, Moranne O, Esnault VL.

Am J Kidney Dis. 2016 Nov;68(5):752-762. doi: 10.1053/j.ajkd.2016.05.013. Epub 2016 Jun 23.


Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease.

Murtagh FE, Burns A, Moranne O, Morton RL, Naicker S.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1909-1914. doi: 10.2215/CJN.04840516. Epub 2016 Aug 10.


Supportive Care: Time to Change Our Prognostic Tools and Their Use in CKD.

Couchoud C, Hemmelgarn B, Kotanko P, Germain MJ, Moranne O, Davison SN.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1892-1901. doi: 10.2215/CJN.12631115. Epub 2016 Aug 10.


Access to and characteristics of palliative care-related hospitalization in the management of end-stage renal disease patients on renal replacement therapy in France.

Couchoud C, Arnaud DB, Lobbedez T, Blanchard S, Chantrel F, Maurizi-Balzan J, Moranne O; REIN registry.

Nephrology (Carlton). 2017 Aug;22(8):598-608. doi: 10.1111/nep.12822.


Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.

Matignon M, Leibler C, Moranne O, Salomon L, Charron D, Lang P, Jacquelinet C, Suberbielle C, Grimbert P.

Clin Transplant. 2016 Jun;30(6):731-40. doi: 10.1111/ctr.12743. Epub 2016 May 2.


Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study.

Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17.


Polymicrobial peritonitis in a peritoneal dialysis patient.

Laurain A, Degand N, Raffaelli C, Moranne O.

Kidney Int. 2015 Dec;88(6):1455. doi: 10.1038/ki.2015.79. No abstract available.


[Dosing adjustment and renal function: Which equation(s)?].

Delanaye P, Flamant M, Cavalier É, Guerber F, Vallotton T, Moranne O, Pottel H, Boffa JJ, Mariat C.

Nephrol Ther. 2016 Feb;12(1):18-31. doi: 10.1016/j.nephro.2015.07.472. Epub 2015 Nov 18. French.


Creatinine-based equations for the adjustment of drug dosage in an obese population.

Bouquegneau A, Vidal-Petiot E, Moranne O, Mariat C, Boffa JJ, Vrtovsnik F, Scheen AJ, Krzesinski JM, Flamant M, Delanaye P.

Br J Clin Pharmacol. 2016 Feb;81(2):349-61. doi: 10.1111/bcp.12817. Epub 2016 Jan 17.


Development of a risk stratification algorithm to improve patient-centered care and decision making for incident elderly patients with end-stage renal disease.

Couchoud CG, Beuscart JB, Aldigier JC, Brunet PJ, Moranne OP; REIN registry.

Kidney Int. 2015 Nov;88(5):1178-86. doi: 10.1038/ki.2015.245. Epub 2015 Sep 2.


Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy.

Delanaye P, Cavalier E, Fafin C, Dubois BE, Krzesinski JM, Moranne O.

J Nephrol. 2016 Feb;29(1):99-103. doi: 10.1007/s40620-015-0196-y. Epub 2015 Apr 10.


Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.


A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation.

Dusseux E, Albano L, Fafin C, Hourmant M, Guérin O, Couchoud C, Moranne O.

Kidney Int. 2015 Jul;88(1):121-9. doi: 10.1038/ki.2015.25. Epub 2015 Feb 11.


A clinically useful risk-score for chronic kidney disease in HIV infection.

Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study group.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19514. doi: 10.7448/IAS.17.4.19514. eCollection 2014.


Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.

Vassallo M, Moranne O, Ambrosetti D, Jeandel PY, Pomares C, Cassuto E, Boscagli A, Giraud G, Montagne N, Dentone C, Demacina I, Villaggio B, Secondo G, Ferrea G, Passeron C, Saudes L, Kaphan R, Marty P, Rosenthal E.

BMC Infect Dis. 2014 Oct 30;14:561. doi: 10.1186/s12879-014-0561-9.


Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.

Nephrol Dial Transplant. 2014 Nov;29(11):2084-91. doi: 10.1093/ndt/gfu209. Epub 2014 Jun 11.


Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group.

BMC Nephrol. 2014 Mar 25;15:51. doi: 10.1186/1471-2369-15-51.


Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons.

Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, Morlat P, Moranne O, Smith C, El-Sadr W, Law M, Lundgren JD.

AIDS. 2014 Jan 14;28(2):187-99. doi: 10.1097/QAD.0000000000000042.


Cutaneous fistula from obstructive pyelonephritis.

Lochouarn MP, Andreani OP, Marsaud AC, Raffaelli CP, Moranne OP.

Kidney Int. 2013 Oct;84(4):851. doi: 10.1038/ki.2013.60. No abstract available.


Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy.

Moranne O, Bakris G, Fafin C, Favre G, Pradier C, Esnault VL.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1694-701. doi: 10.2215/CJN.06960712. Epub 2013 Aug 8.


Patients' preferences regarding choice of end-stage renal disease treatment options.

Maaroufi A, Fafin C, Mougel S, Favre G, Seitz-Polski B, Jeribi A, Vido S, Dewisme C, Albano L, Esnault V, Moranne O.

Am J Nephrol. 2013;37(4):359-69. doi: 10.1159/000348822. Epub 2013 Mar 23.


MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients.

Masson I, Flamant M, Maillard N, Rule AD, Vrtovsnik F, Peraldi MN, Thibaudin L, Cavalier E, Vidal-Petiot E, Bonneau C, Moranne O, Alamartine E, Mariat C, Delanaye P.

Transplantation. 2013 May 27;95(10):1211-7. doi: 10.1097/TP.0b013e318288caa6.


Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease.

Delanaye P, Cavalier E, Moranne O, Lutteri L, Krzesinski JM, Bruyère O.

BMC Nephrol. 2013 Mar 12;14:57. doi: 10.1186/1471-2369-14-57.


Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group.

J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4.


[The First International Seminars on renal Epidemiology held In Paris,France, in May 2012].

Couchoud C, Moranne O, Vigneau C, Villar E.

Nephrol Ther. 2013 Feb;9(1):50-6. doi: 10.1016/j.nephro.2012.08.001. French. No abstract available.


Variability of new bone mineral metabolism markers in patients treated with maintenance hemodialysis: implications for clinical decision making.

Cavalier E, Delanaye P, Moranne O.

Am J Kidney Dis. 2013 May;61(5):847-8. doi: 10.1053/j.ajkd.2012.12.013. Epub 2013 Jan 26. No abstract available.


Rate of renal graft function decline after one year is a strong predictor of all-cause mortality.

Moranne O, Maillard N, Fafin C, Thibaudin L, Alamartine E, Mariat C.

Am J Transplant. 2013 Mar;13(3):695-706. doi: 10.1111/ajt.12053. Epub 2013 Jan 11.


Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?

Delanaye P, Dubois BE, Jouret F, Krzesinski JM, Moranne O, Cavalier E.

Clin Chim Acta. 2013 Feb 18;417:35-8. doi: 10.1016/j.cca.2012.12.009. Epub 2012 Dec 21.


GFR estimation using standardized cystatin C in kidney transplant recipients.

Masson I, Maillard N, Tack I, Thibaudin L, Dubourg L, Delanaye P, Cavalier E, Bonneau C, Kamar N, Morelon E, Moranne O, Alamartine E, Mariat C.

Am J Kidney Dis. 2013 Feb;61(2):279-84. doi: 10.1053/j.ajkd.2012.09.010. Epub 2012 Nov 8. Erratum in: Am J Kidney Dis. 2013 Aug;62(2):401.


Characteristics and treatment course of patients older than 75 years, reaching end-stage renal failure in France. The PSPA study.

Moranne O, Couchoud C, Vigneau C; PSPA Study Investigators.

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1394-9. doi: 10.1093/gerona/gls162. Epub 2012 Oct 9.


Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study.

Janus N, Launay-Vacher V, Thyss A, Boulanger H, Moranne O, Islam MS, Durande JP, Ducret M, Juillard L, Soltani Z, Motte G, Rottembourg J, Deray G, Thariat J.

Ann Oncol. 2013 Feb;24(2):501-7. doi: 10.1093/annonc/mds344. Epub 2012 Oct 4.


Supplemental Content

Loading ...
Support Center